Genomic Expression, Inc. — Form D

Genomic Expression, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-06-25. The offering totals $500K, of which $200K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2014-06-25
• Form: D
• Accession: 0001611868-14-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $500K
• Amount sold: $200K
• Remaining: $300K
• Investors: 3
• Date of first sale: 2014-06-15
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-219784

Issuer

• Name: Genomic Expression, Inc.
• CIK: 0001611868
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2009
• Address: 375 PARK AVENUE, NEW YORK, NY, 10152
• Phone: (828) 475-5552

Officers, directors & promoters (8)

More

• CIK 1611868 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search